Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Reynolds Donald Rogers Insider Profile
4 Followers
Reynolds Donald Rogers, Director at Oncotelic Therapeutics, holds 280.00K shares in Oncotelic Therapeutics (Ticker: OTLC).
Reynolds Donald Rogers has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Reynolds Donald Rogers's holdings
Insider Roles
Director
Roles that Reynolds Donald Rogers holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 20, 2016 - Dec 20, 2017
Return:-55.80%
The most profitable trade made by Reynolds Donald Rogers
Reynolds Donald Rogers's Trading History
List of latest transactions for each holding click on a transaction to see Reynolds Donald Rogers's performance on stock
You May Also Like
Reynolds Donald Rogers insider profile FAQ
What is the percentage of profitable transactions made by Reynolds Donald Rogers?
The percentage of profitable transactions made by Reynolds Donald Rogers is ―.
What is the average return per transaction made by Reynolds Donald Rogers?
The average return per transaction made by Reynolds Donald Rogers is ―.
What stocks does Reynolds Donald Rogers hold?
Reynolds Donald Rogers holds: OTLC stocks.
What was Reynolds Donald Rogers’s latest transaction?
Reynolds Donald Rogers latest transaction was an Uninformative Buy of ―.
What was Reynolds Donald Rogers's most profitable transaction?
Reynolds Donald Rogers’s most profitable transaction was an Informative Buy of OTLC stock on December 20, 2016. The return on the trade was -55.80%.
What is Reynolds Donald Rogers's role in Oncotelic Therapeutics?
Reynolds Donald Rogers's role in Oncotelic Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.